Identification of novel biomarker hsa_circ_0003914 for rheumatoid arthritis from plasma exosomes

• Published in: International immunopharmacology 2024-09, Vol.138, p.112562, Article 112562
• Main Authors: He, Qian, Sha, Xiaoqi, Ji, Juan, liu, Wanli, Sun, Chi, Gu, Zhifeng
• Format: Article
• Language: English
• Subjects: Animals; Arthritis, Experimental - blood; Arthritis, Experimental - genetics; Arthritis, Experimental - immunology; Arthritis, Rheumatoid - blood; Arthritis, Rheumatoid - genetics; Arthritis, Rheumatoid - immunology; Biomarkers - blood; Cell Movement; Cell Proliferation; Cells, Cultured; Exosomes; Exosomes - metabolism; Female; Fibroblast-like synoviocytes; Hsa_circ_0003914; Humans; Male; Mice; Mice, Inbred DBA; Middle Aged; Rheumatoid arthritis; RNA, Circular - genetics; Synoviocytes - metabolism
• ISSN: 1567-5769; 1878-1705; 1878-1705
• DOI: 10.1016/j.intimp.2024.112562

•lhsa_circ_0003914 was shown to be associated with clinical disease activity in patients lplasma exosomes.•hsa_circ_0003914 promoted progression of rheumatoid arthritis by modulating the NF-κB/p65 signaling pathway.•lExosomal hsa_circ_0003914 derived from plasma is a promising and effective non-invasive biomarker for R. Rheumatoid arthritis (RA) is a complex autoimmune disease featuring invasive and infiltrative fibroblast-like synoviocytes (FLS) that lead to joint damage. While current RA pathological mechanisms remain incompletely defined, exosomes have been implicated as having the potential to drive disease progression due to their ability to deliver different types of biomolecules to tissues effected by RA. One potentially disease exacerbating molecule type found in exosomes are Circular RNAs (circRNAs), which are highly stable and have been previously implicated in RA pathogenesis. Here, we examine hsa_circ_0003914, a circRNA found in exosomes located in blood plasma, for a role in RA. Plasma exosomes were isolated and injected into collagen-induced arthritis (CIA) mice, followed by functional experiments to analyze the influence of exosomes on FLS formation. Sequencing revealed the presence of hsa_circ_0003914 in exosomes, so we examined its association with clinical markers in RA. Finally, the role for hsa_circ_0003914 in RA was directly confirmed through in vivo and in vitro experiments. We found that plasma exosomes isolated from RA patients could aggravate the disease of CIA mice, compared to exosomes isolated from healthy control patients. Hsa_circ_0003914 was highly enriched in the exosomes of RA patients. Mechanistically, Hsa_circ_0003914 promoted abnormal cell proliferation, migration, invasion and stimulated the secretion of inflammatory cytokines in FLSs through targeting NF-κB/p65 signaling pathway. Interestingly, knockdown of hsa_circ_0003914 rescued disease phenotypes in CIA mice. Taken together, these data implicate hsa_circ_0003914 as a potential therapeutic target for the prevention and management of RA.